EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges

Wojciech Szymanowski iD, Anna Szymanowska, Anna Bielawska, Gabriel Lopez-Berestein, Cristian Rodriguez-Aguayo iD, Paola Amero iD

Cancers · 06.11.2023 · 15 (21) · 5300

DOI: 10.3390/cancers15215300 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 06.11.2023. Verfasst von Wojciech Szymanowski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Medical University of Bialystok, 15-222 Bialystok, Poland. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Polish National Agency for Academic Exchange (NAWA) within the Bekker Programme, Medical University of Bialystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) is the most common lethal gynecologic cause of death in women worldwide, with a high mortality rate and increasing incidence. Despite advancements in the treatment, most OC patients still die from their disease due to late-stage diagnosis, the lack of effective diagnostic methods, and relapses. Aptamers, synthetic, short single-stranded oligonucleotides, have emerged as promising anticancer therapeutics. Their ability to selectively bind to target molecules, including cancer-related proteins and receptors, has revolutionized drug discovery and biomarker identification. Aptamers offer unique insights into the molecular pathways involved in cancer development and progression. Moreover, they show immense potential as drug delivery systems, enabling targeted delivery of therapeutic agents to cancer cells while minimizing off-target effects and reducing systemic toxicity. In the context of OC, the integration of aptamers with non-coding RNAs (ncRNAs) presents an opportunity for precise and efficient gene targeting. Additionally, the conjugation of aptamers with nanoparticles allows for accurate and targeted delivery of ncRNAs to specific cells, tissues, or organs. In this review, we will summarize the potential use and challenges associated with the use of aptamers alone or aptamer–ncRNA conjugates, nanoparticles, and multivalent aptamer-based therapeutics for the treatment of OC.

Schlagwörter

Stichwörter der Autor:innen

aptamersovarian cancertargeted delivery systemtherapeuticstumor microenvironment

Autor:innen und Institutionen

  • Department of Biotechnology, Medical University of Bialystok, 15-222 Bialystok, Poland.
  • Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

ORCID-Profile: Wojciech Szymanowski, Cristian Rodriguez-Aguayo, Paola Amero

Förderung

  • Polish National Agency for Academic Exchange (NAWA) within the Bekker Programme
  • Medical University of Bialystok

Zitieren

APA

Szymanowski, W., Szymanowska, A., Bielawska, A., Lopez-Berestein, G., Rodriguez-Aguayo, C., & Amero, P. (2023). Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges. Cancers, 15(21), 5300. https://doi.org/10.3390/cancers15215300

Vancouver

Szymanowski W, Szymanowska A, Bielawska A, Lopez-Berestein G, Rodriguez-Aguayo C, Amero P. Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges. Cancers. 2023;15(21):5300. doi:10.3390/cancers15215300

BibTeX
@article{Szymanowski2023,
  author = {Szymanowski, Wojciech and Szymanowska, Anna and Bielawska, Anna and Lopez-Berestein, Gabriel and Rodriguez-Aguayo, Cristian and Amero, Paola},
  title = {Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {21},
  pages = {5300},
  doi = {10.3390/cancers15215300}
}
Kostenlos starten →